Association between amyloid-beta deposition and cortical thickness in dementia with Lewy bodies

Aust N Z J Psychiatry. 2023 Apr;57(4):594-602. doi: 10.1177/00048674221081773. Epub 2022 Feb 24.

Abstract

Objective: Amyloid-beta often co-exists in dementia with Lewy bodies, but its clinical relevance in dementia with Lewy bodies remains unclear. This study aimed to investigate the clinical and imaging correlates of amyloid-beta deposition in dementia with Lewy bodies, particularly its relationship with cortical thickness in Alzheimer's disease-prone regions and hippocampal volume.

Methods: Twenty-four participants with probable dementia with Lewy bodies underwent high-resolution magnetic resonance imaging and amyloid-beta positron emission tomography imaging using the radiotracer 18F-NAV4694. Amyloid-beta deposition was quantified and reported using the Centiloid method.

Results: Amyloid-beta positivity, defined as Centiloid > 50, was present in 45.8% of dementia with Lewy bodies participants. There were no statistically significant differences in clinical characteristics between Aβ+ and Aβ- dementia with Lewy bodies. Compared with the Aβ- group, Aβ+ dementia with Lewy bodies exhibited greater global cortical thinning as well as in the Alzheimer's disease-prone region of interest, adjusted for age, sex and years of education. A mean cortical thickness of 5.12 mm across a combined meta-region of interest has a sensitivity of 88.9% and specificity of 90.0% in discriminating Aβ+ from Aβ- dementia with Lewy bodies. Hippocampal volume was not different between groups.

Conclusion: Early structural changes in cortical thickness, but not hippocampal volume, were observed in dementia with Lewy bodies with significant amyloid-beta burden. This may represent an early Alzheimer's disease-related neurodegenerative process.

Keywords: Alzheimer’s disease; Dementia with Lewy bodies; amyloid-beta; cortical thickness.

MeSH terms

  • Alzheimer Disease* / diagnostic imaging
  • Amyloid beta-Peptides / metabolism
  • Hippocampus / diagnostic imaging
  • Hippocampus / pathology
  • Humans
  • Lewy Body Disease* / diagnostic imaging
  • Lewy Body Disease* / pathology
  • Positron-Emission Tomography / methods

Substances

  • Amyloid beta-Peptides